HCP 2001
Alternative Names: HCP-2001Latest Information Update: 29 Dec 2021
At a glance
- Originator Hanmi Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 17 Dec 2021 HCP 2001 is available for licensing as of 17 Dec 2021. http://www.hanmipharm.com/ehanmi/handler/Business-GlobalOut
- 21 Oct 2021 Phase-I clinical trials in Unspecified (In volunteers) in South Korea (unspecified route) (NCT05155995)